US Stock MarketDetailed Quotes

Ekso Bionics (EKSO)

Watchlist
  • 11.790
  • -0.220-1.83%
Close May 1 16:00 ET
  • 11.960
  • +0.170+1.44%
Post 20:01 ET
42.01MMarket Cap-2.31P/E (TTM)

Ekso Bionics (EKSO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
-36.56%2.14M
-28.60%12.8M
-38.31%3.14M
2.37%4.23M
-58.44%2.06M
-10.14%3.38M
-1.94%17.93M
5.01%5.09M
-10.38%4.13M
5.25%4.95M
Operating revenue
-36.56%2.14M
-26.24%12.52M
-30.90%2.86M
2.37%4.23M
-58.66%1.98M
-10.14%3.38M
-5.30%16.97M
-7.84%4.14M
-10.38%4.13M
4.35%4.8M
Cost of revenue
-31.99%1.07M
-29.24%5.95M
-38.17%1.47M
-12.60%1.68M
-46.48%1.24M
-13.07%1.57M
-8.54%8.41M
-4.12%2.38M
-10.74%1.92M
-5.55%2.31M
Gross profit
-40.53%1.07M
-28.03%6.85M
-38.43%1.67M
15.39%2.55M
-68.94%819K
-7.43%1.81M
4.76%9.51M
14.56%2.71M
-10.06%2.21M
16.99%2.64M
Operating expense
27.56%6.69M
1.00%20.17M
25.00%6.18M
-18.50%3.95M
-3.58%4.79M
0.75%5.25M
-17.44%19.97M
-15.02%4.94M
-10.01%4.85M
-23.95%4.97M
Selling and administrative expenses
43.47%6.11M
6.48%17.14M
35.11%5.54M
-16.46%3.4M
2.23%3.94M
4.59%4.26M
-16.01%16.1M
-9.01%4.1M
-3.71%4.07M
-24.98%3.86M
-Selling and marketing expense
20.15%2.05M
-2.11%7.15M
29.72%2.44M
-25.40%1.31M
-8.45%1.69M
-6.11%1.71M
-13.74%7.31M
-4.99%1.88M
-14.23%1.76M
-21.41%1.85M
-General and administrative expense
59.07%4.06M
13.62%9.99M
39.68%3.09M
-9.65%2.09M
12.04%2.25M
13.23%2.55M
-17.81%8.79M
-12.17%2.22M
6.20%2.31M
-27.98%2.01M
Research and development costs
-40.99%583K
-21.76%3.03M
-24.02%642K
-29.21%550K
-23.66%852K
-13.03%988K
-22.91%3.87M
-35.64%845K
-32.96%777K
-20.17%1.12M
Operating profit
-63.31%-5.62M
-27.40%-13.33M
-102.20%-4.51M
46.87%-1.4M
-70.24%-3.98M
-5.65%-3.44M
30.78%-10.46M
35.34%-2.23M
9.96%-2.64M
45.49%-2.34M
Net non-operating interest income expense
-300.00%-288K
-14.87%-309K
-162.71%-155K
77.22%-18K
12.16%-65K
-26.32%-72K
10.93%-269K
10.61%-59K
-23.44%-79K
-21.31%-74K
Non-operating interest expense
98.61%143K
14.87%309K
162.71%155K
-77.22%18K
-12.16%65K
26.32%72K
-10.93%269K
-10.61%59K
23.44%79K
21.31%74K
Total other finance cost
--145K
----
----
----
----
----
----
----
----
----
Other net income (expense)
-257.65%-979K
422.80%1.94M
99.11%-10K
-100.15%-1K
19,114.29%1.33M
635.34%621K
-378.24%-601K
-473.42%-1.12M
274.59%646K
-106.09%-7K
Gain on sale of security
-254.07%-966K
427.67%1.97M
99.64%-4K
-99.38%4K
19,228.57%1.34M
640.52%627K
-315.05%-600K
-456.01%-1.13M
273.73%648K
-104.83%-7K
Other non- operating income (expenses)
-116.67%-13K
-2,500.00%-26K
-700.00%-6K
-150.00%-5K
---8K
---6K
98.41%-1K
106.67%1K
-166.67%-2K
----
Income before tax
-138.15%-6.89M
-3.22%-11.7M
-36.95%-4.67M
31.42%-1.42M
-12.13%-2.71M
15.69%-2.89M
25.45%-11.33M
-6.19%-3.41M
38.42%-2.07M
42.88%-2.42M
Income tax
Net income
-138.15%-6.89M
-3.22%-11.7M
-36.95%-4.67M
31.42%-1.42M
-12.13%-2.71M
15.69%-2.89M
25.45%-11.33M
-6.19%-3.41M
38.42%-2.07M
42.88%-2.42M
Net income continuous Operations
-138.15%-6.89M
-3.22%-11.7M
-36.95%-4.67M
31.42%-1.42M
-12.13%-2.71M
15.69%-2.89M
25.45%-11.33M
-6.19%-3.41M
38.42%-2.07M
42.88%-2.42M
Minority interest income
Net income attributable to the parent company
-138.15%-6.89M
-3.22%-11.7M
-36.95%-4.67M
31.42%-1.42M
-12.13%-2.71M
15.69%-2.89M
25.45%-11.33M
-6.19%-3.41M
38.42%-2.07M
42.88%-2.42M
Preferred stock dividends
Other preferred stock dividends
66.37%376K
226K
Net income attributable to common stockholders
-132.95%-7.26M
-3.22%-11.7M
-36.95%-4.67M
31.42%-1.42M
-12.13%-2.71M
9.10%-3.12M
25.45%-11.33M
-6.19%-3.41M
38.42%-2.07M
42.88%-2.42M
Basic earnings per share
-10.87%-2.04
41.76%-4.91
25.71%-1.56
64.71%-0.54
37.69%-1.24
38.67%-1.84
48.91%-8.43
36.36%-2.1
57.50%-1.53
57.20%-1.99
Diluted earnings per share
-10.87%-2.04
41.76%-4.91
25.71%-1.56
64.71%-0.54
37.69%-1.24
38.67%-1.84
48.91%-8.43
36.36%-2.1
57.50%-1.53
57.20%-1.99
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue -36.56%2.14M-28.60%12.8M-38.31%3.14M2.37%4.23M-58.44%2.06M-10.14%3.38M-1.94%17.93M5.01%5.09M-10.38%4.13M5.25%4.95M
Operating revenue -36.56%2.14M-26.24%12.52M-30.90%2.86M2.37%4.23M-58.66%1.98M-10.14%3.38M-5.30%16.97M-7.84%4.14M-10.38%4.13M4.35%4.8M
Cost of revenue -31.99%1.07M-29.24%5.95M-38.17%1.47M-12.60%1.68M-46.48%1.24M-13.07%1.57M-8.54%8.41M-4.12%2.38M-10.74%1.92M-5.55%2.31M
Gross profit -40.53%1.07M-28.03%6.85M-38.43%1.67M15.39%2.55M-68.94%819K-7.43%1.81M4.76%9.51M14.56%2.71M-10.06%2.21M16.99%2.64M
Operating expense 27.56%6.69M1.00%20.17M25.00%6.18M-18.50%3.95M-3.58%4.79M0.75%5.25M-17.44%19.97M-15.02%4.94M-10.01%4.85M-23.95%4.97M
Selling and administrative expenses 43.47%6.11M6.48%17.14M35.11%5.54M-16.46%3.4M2.23%3.94M4.59%4.26M-16.01%16.1M-9.01%4.1M-3.71%4.07M-24.98%3.86M
-Selling and marketing expense 20.15%2.05M-2.11%7.15M29.72%2.44M-25.40%1.31M-8.45%1.69M-6.11%1.71M-13.74%7.31M-4.99%1.88M-14.23%1.76M-21.41%1.85M
-General and administrative expense 59.07%4.06M13.62%9.99M39.68%3.09M-9.65%2.09M12.04%2.25M13.23%2.55M-17.81%8.79M-12.17%2.22M6.20%2.31M-27.98%2.01M
Research and development costs -40.99%583K-21.76%3.03M-24.02%642K-29.21%550K-23.66%852K-13.03%988K-22.91%3.87M-35.64%845K-32.96%777K-20.17%1.12M
Operating profit -63.31%-5.62M-27.40%-13.33M-102.20%-4.51M46.87%-1.4M-70.24%-3.98M-5.65%-3.44M30.78%-10.46M35.34%-2.23M9.96%-2.64M45.49%-2.34M
Net non-operating interest income expense -300.00%-288K-14.87%-309K-162.71%-155K77.22%-18K12.16%-65K-26.32%-72K10.93%-269K10.61%-59K-23.44%-79K-21.31%-74K
Non-operating interest expense 98.61%143K14.87%309K162.71%155K-77.22%18K-12.16%65K26.32%72K-10.93%269K-10.61%59K23.44%79K21.31%74K
Total other finance cost --145K------------------------------------
Other net income (expense) -257.65%-979K422.80%1.94M99.11%-10K-100.15%-1K19,114.29%1.33M635.34%621K-378.24%-601K-473.42%-1.12M274.59%646K-106.09%-7K
Gain on sale of security -254.07%-966K427.67%1.97M99.64%-4K-99.38%4K19,228.57%1.34M640.52%627K-315.05%-600K-456.01%-1.13M273.73%648K-104.83%-7K
Other non- operating income (expenses) -116.67%-13K-2,500.00%-26K-700.00%-6K-150.00%-5K---8K---6K98.41%-1K106.67%1K-166.67%-2K----
Income before tax -138.15%-6.89M-3.22%-11.7M-36.95%-4.67M31.42%-1.42M-12.13%-2.71M15.69%-2.89M25.45%-11.33M-6.19%-3.41M38.42%-2.07M42.88%-2.42M
Income tax
Net income -138.15%-6.89M-3.22%-11.7M-36.95%-4.67M31.42%-1.42M-12.13%-2.71M15.69%-2.89M25.45%-11.33M-6.19%-3.41M38.42%-2.07M42.88%-2.42M
Net income continuous Operations -138.15%-6.89M-3.22%-11.7M-36.95%-4.67M31.42%-1.42M-12.13%-2.71M15.69%-2.89M25.45%-11.33M-6.19%-3.41M38.42%-2.07M42.88%-2.42M
Minority interest income
Net income attributable to the parent company -138.15%-6.89M-3.22%-11.7M-36.95%-4.67M31.42%-1.42M-12.13%-2.71M15.69%-2.89M25.45%-11.33M-6.19%-3.41M38.42%-2.07M42.88%-2.42M
Preferred stock dividends
Other preferred stock dividends 66.37%376K226K
Net income attributable to common stockholders -132.95%-7.26M-3.22%-11.7M-36.95%-4.67M31.42%-1.42M-12.13%-2.71M9.10%-3.12M25.45%-11.33M-6.19%-3.41M38.42%-2.07M42.88%-2.42M
Basic earnings per share -10.87%-2.0441.76%-4.9125.71%-1.5664.71%-0.5437.69%-1.2438.67%-1.8448.91%-8.4336.36%-2.157.50%-1.5357.20%-1.99
Diluted earnings per share -10.87%-2.0441.76%-4.9125.71%-1.5664.71%-0.5437.69%-1.2438.67%-1.8448.91%-8.4336.36%-2.157.50%-1.5357.20%-1.99
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More